SeqCure Immunology AB
Developing personalized, non-genetically engineered cell therapy for advanced cancer.
Oversigt
- 1
- Medarbejdere
- -1 SEK
- Omsætning
- 2016
- Grundlagt
Beskrivelse
SeqCure Immunology is a Stockholm-based biotechnology startup dedicated to advancing cancer immunotherapies. The company is developing SeqCureNEO, a novel, curative, personalized cell therapy designed for treating advanced-stage cancers. This therapy is manufactured using the patient's own isolated...
Tags
Nøgleord
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559094703101
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
CuraCell TX AB
5 medarbejdereEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Stallergenes Greer Sverige filial
Global biopharma leader diagnosing and treating allergies via immunotherapy.
STOCKHOLM CANCER CLUSTER
0 medarbejdereNon-profit foundation providing infrastructure for translational cancer research.
SpectraCure AB (publ)
10–19 medarbejdereDeveloping precise, minimally invasive PDT systems for solid tumor treatment.
Novocure Sweden AB
0 medarbejdereGlobal oncology company commercializing Tumor Treating Fields therapy for cancer.
Udforsk mere
Spørgsmål om SeqCure Immunology AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo